India, Aug. 14 -- The Exchange has sought clarification from Dr Reddys Laboratories Ltd on August 14, 2019, with reference to news appeared in www.bloombergquint.com dated August 14, 2019 quoting "Setback For Dr. Reddy s As U.S. FDA Hands Out Complete Response Letter For NuvaRing "The reply is awaited.

Published by HT Digital Content Services with permission from ACCORD FINTECH BSE....